The BIOSTAT CHF (Biology Study to Tailored Treatment in Chronic Heart Failure) study found that IL-6 could independently predict several key outcomes, including the combined result of all-cause mortality and unscheduled hospitalization for heart failure within 2 years, as well as overall mortality and cardiovascular and non-cardiovascular mortality [71]. This evidence concerns the gene IL6 and congestive heart failure.